pe
pep-05247 v1 CC-BY-SA-4.0

Beta-defensin 135 anticancer peptide

A lab-made peptide being studied for its potential to fight cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length54 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.324
avg pLDDT51.0
ranking score0.473
STRUCTURE · PEP-05247 × ANTICANCER
ranking0.473
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence54 aa
1510152025303540455054
GPNVYIQKIFASCWRLQG TCRPKCLKNETISYFGVI LYICGCVNPKYLPILTGK
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.4730379283428192 boltz-2
3-letter notation
Gly-Pro-Asn-Val-Tyr-Ile-Gln-Lys-Ile-Phe-Ala-Ser-Cys-Trp-Arg-Leu-Gln-Gly-Thr-Cys-Arg-Pro-Lys-Cys-Leu-Lys-Asn-Glu-Thr-Ile-Ser-Tyr-Phe-Gly-Val-Ile-Leu-Tyr-Ile-Cys-Gly-Cys-Val-Asn-Pro-Lys-Tyr-Leu-Pro-Ile-Leu-Thr-Gly-Lys
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Beta-defensin 135 anticancer peptide (pep-05247, v1). PeptideModel. https://peptidemodel.com/card/pep-05247
@peptide{pep05247,
  sequence = {GPNVYIQKIFASCWRLQGTCRPKCLKNETISYFGVILYICGCVNPKYLPILTGK},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use